ArticleCancer discovery2016

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.

Tanner M Johanns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.